Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitis

被引:9
作者
Alazmi, Waleed M.
Regev, Arie
Molina, Enrique G.
Schiff, Eugene R.
机构
[1] Univ Miami, Leonard M Miller Sch Med, Div Hepatol, Ctr Liver Dis, Miami, FL 33136 USA
[2] Univ Miami, Leonard M Miller Sch Med, Div Gastroenterol, Ctr Liver Dis, Miami, FL 33136 USA
关键词
nonalcoholic steatohepatitis; nonalcoholic fatty liver disease; fibrosis; cirrhosis; Hispanics; Caucasians;
D O I
10.1007/s10620-005-9065-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
It is estimated that 43% of patients with nonalcoholic steatohepatitis (NASH) will progress to liver fibrosis or cirrhosis. Although NASH is more common in Hispanics, most studies have been conducted on Caucasians, and there is scarce information regarding ethnic differences in this disease. The aim of this study was to identify the independent predictors of cirrhosis in Hispanic patients with NASH. A retrospective case-control study was conducted on 80 patients with biopsy-proven NASH. Forty-two were Hispanic (study group) and 38 were Caucasians controlled for age and BMI (control group). Clinical, biochemical, and histologic features were analyzed for correlation with cirrhosis. There were no significant differences in demographic features between the two groups. In multivariate analysis, independent predictors of cirrhosis among Hispanic patients were age (OR, 1.07; 95% CI, 1.01-1.14) and AST/ALT ratio (OR, 10.56; 95% Cl; 2.46-45.29), while independent predictors among non-Hispanic patients were age (OR, 1.085; 95% CI, 1.0-1.186), and diabetes mellitus (OR, 6.46; 95% Cl, 1.19-35.07). In patients with NASH, predictors of cirrhosis varied according to ethnic background. Age was an independent predictor in both groups, however, AST/ALT ratio was found to be an independent predictor of cirrhosis only in Hispanic patients, and diabetes mellitus only in non-Hispanic patients.
引用
收藏
页码:1725 / 1729
页数:5
相关论文
共 33 条
[11]   Nonalcoholic Fatty Liver Disease: A Review of Current Understanding and Future Impact [J].
Charlton, Michael .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) :1048-1058
[12]   HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity [J].
Chitturi, S ;
Weltman, M ;
Farrell, GC ;
McDonald, D ;
Liddle, C ;
Samarasinghe, D ;
Lin, R ;
Abeygunasekera, S ;
George, J .
HEPATOLOGY, 2002, 36 (01) :142-149
[13]   Nonalcoholic fatty liver disease - An underrecognized cause of cryptogenic cirrhosis [J].
Clark, JM ;
Diehl, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (22) :3000-3004
[14]   The clinicopathologic spectrum and management of nonalcoholic fatty liver disease [J].
Contos, MJ ;
Sanyal, TJ .
ADVANCES IN ANATOMIC PATHOLOGY, 2002, 9 (01) :37-51
[15]   Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese [J].
Dixon, JB ;
Bhathal, PS ;
O'Brien, PE .
GASTROENTEROLOGY, 2001, 121 (01) :91-100
[16]   FATTY INFILTRATION OF THE LIVER - ANALYSIS OF PREVALENCE, RADIOLOGICAL AND CLINICAL-FEATURES AND INFLUENCE ON PATIENT-MANAGEMENT [J].
ELHASSAN, AY ;
IBRAHIM, EM ;
ALMULHIM, FA ;
NABHAN, AA ;
CHAMMAS, MY .
BRITISH JOURNAL OF RADIOLOGY, 1992, 65 (777) :774-778
[17]   Overweight and obesity in the United States: prevalence and trends, 1960-1994 [J].
Flegal, KM ;
Carroll, MD ;
Kuczmarski, RJ ;
Johnson, CL .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (01) :39-47
[18]   Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity [J].
García-Monzón, C ;
Martín-Pérez, E ;
Lo Iacono, O ;
Fernández-Bermejo, M ;
Majano, PL ;
Apolinario, A ;
Larrañaga, E ;
Moreno-Otero, R .
JOURNAL OF HEPATOLOGY, 2000, 33 (05) :716-724
[19]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[20]  
Harrison SA, 2003, HEPATOLOGY, V38, p511A